The global generative AI in medicine market size is calculated at USD 1,063.53 million in 2024, grew to USD 1,549.45 million in 2025, and is predicted to hit around USD 45,819.11 million by 2034, expanding at a CAGR of 45.69% between 2024 and 2034. The North America generative AI in medicine market size accounted for USD 467.95 million in 2024 and is anticipated to grow at the fastest CAGR of 45.85% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Generative AI in Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Generative AI in Medicine Market, by Deployment, 2024-2034
8.1.1 Cloud-based
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. On-premises
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Generative AI in Medicine Market, by Application, 2024-2034
9.1.1. Medical Imaging
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Drug Discovery
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Medical Diagnosis
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Patient Data Analysis
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Other
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Generative AI in Medicine Market, by End-User, 2024-2034
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Clinical Research
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Healthcare Organizations
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Diagnostic Centers
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Other
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.1.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Forecast, by End-User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End-User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Deployment (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End-User (2021-2034)
12.1. Nuance Communications, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. IBM Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Microsoft
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. NVIDIA Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Intel Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. DeepMind Technologies Limited
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample